Skip to Main Content
Recruiting

NLPHLPRO: Quality of Life in NLPHL Patients

About this study

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare cancer of the lymphatic system, which helps fight infections. NLPHL can be monitored over time or treated in many different ways. Doctors want to learn more about quality of life, symptom experience, and emotional health for people with NLPHL. 

The goal of this study is to better understand how people with NLPHL feel during and after treatment. We want to create and test a system that helps researchers collect this information in a safe and dependable way. This will show if it is possible to gather this type of data from many patients over time.

Researchers will ask patients to complete surveys about their physical health, emotions, and daily activities. These surveys will help track how patients’ experiences change over time based on their age, disease stage, and the type of treatment they receive.

The study will also ask each patient’s care providers to answer questions about the patient’s health. Along with the patient report, these details will help us learn what life is like for people with NLPHL and how care can be improved in the future.

Participants will complete surveys at the start of the study and every 3 months for 1 year. Surveys can be done online.  

Taking part in this study may not directly benefit participants, but it will help doctors learn more about how having NLPHL and different treatments affect quality of life. The information collected will guide future care and help researchers design treatments that cause fewer side effects. The goal is to improve long-term health and well-being of children and adults living with this rare cancer.

Eligibility overview

  • Diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma
  • 8 years and older

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.

Overview

Full title:

A Pilot Study of Prospective Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients with Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Study goal:

To build and test a system to collect information from patients to understand how treatment affects quality of life and well-being in people with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).

Diagnosis:

Nodular lymphocyte-predominant Hodgkin lymphoma

Age:

8 years and older

Clinical trial categories:

Childhood Cancer Hodgkin Lymphoma

For physicians and researchers

Patients accepted to St. Jude must be referred by a physician or other qualified medical professional. Learn how St. Jude can partner with you to care for your patient.

 

Learn more